Michela Ortoncelli

2.1k total citations
56 papers, 741 citations indexed

About

Michela Ortoncelli is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, Michela Ortoncelli has authored 56 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Dermatology, 29 papers in Immunology and 22 papers in Physiology. Recurrent topics in Michela Ortoncelli's work include Dermatology and Skin Diseases (38 papers), Asthma and respiratory diseases (22 papers) and Psoriasis: Treatment and Pathogenesis (21 papers). Michela Ortoncelli is often cited by papers focused on Dermatology and Skin Diseases (38 papers), Asthma and respiratory diseases (22 papers) and Psoriasis: Treatment and Pathogenesis (21 papers). Michela Ortoncelli collaborates with scholars based in Italy, Belarus and United States. Michela Ortoncelli's co-authors include Pietro Quaglino, Maria Teresa Fierro, Maria Grazia Bernengo, Simone Ribero, Luca Mastorino, Simona Osella‐Abate, Paola Savoia, Paolo Dapavo, N Cappello and Federica Marenco and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Journal of Investigative Dermatology.

In The Last Decade

Michela Ortoncelli

45 papers receiving 733 citations

Peers

Michela Ortoncelli

DERMA

IMMUN

ONCOL

PHYSI

Jocelyne Papacharalambous United States

Tomonori Takekoshi Japan

Tomas Norman Dam Denmark

M. Carducci Italy

Svitlana Tatulych United States

Ray A. Johnson United States

Julie Parmentier United States

Anna‐Karin Ekman Sweden

Laura F. Morris United States

Hilda E. Ramón United States

Jocelyne Papacharalambous United States

Michela Ortoncelli

600 ×1.4

DERMA

370 ×1.0

IMMUN

126 ×0.8

ONCOL

312 ×2.0

177 ×1.2

PHYSI

Citations per year, relative to Michela Ortoncelli Michela Ortoncelli (= 1×) peers Jocelyne Papacharalambous

Countries citing papers authored by Michela Ortoncelli

Since Specialization

Citations

This map shows the geographic impact of Michela Ortoncelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Ortoncelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Ortoncelli more than expected).

Fields of papers citing papers by Michela Ortoncelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Ortoncelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Ortoncelli. The network helps show where Michela Ortoncelli may publish in the future.

Co-authorship network of co-authors of Michela Ortoncelli

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Ortoncelli. A scholar is included among the top collaborators of Michela Ortoncelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Ortoncelli. Michela Ortoncelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cavaliere, Giovanni, et al.. (2026). Toxic epidermal necrolysis induced by lamotrigine with suspected venlafaxine-related relapse. Italian Journal of Dermatology and Venereology.

Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing. Experimental Dermatology. 34(2). e70062–e70062. 2 indexed citations

Mastorino, Luca, Pedro Mendes‐Bastos, Giovanni Cavaliere, et al.. (2025). Super Responders in Moderate-to-Severe Atopic Dermatitis Under Treatment with Dupilumab: An Explorative Real-World Study. Journal of Clinical Medicine. 14(10). 3480–3480.

Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years. Clinical and Experimental Dermatology. 51(1). 35–41.

Conti, Luca, et al.. (2025). A case of lupus-like reaction following the administration of anti-TNFα in a patient with hidradenitis suppurativa. Italian Journal of Dermatology and Venereology. 160(3). 294–296.

Mastorino, Luca, et al.. (2024). Therapeutic Modulation of Dupilumab in Patients with Severe Atopic Dermatitis®: Clinical Effectiveness in Real Life. Dermatitis. 35(6). 625–635. 1 indexed citations

Roccuzzo, Gabriele, et al.. (2024). Pyoderma gangrenosum during infliximab in severe hidradenitis suppurativa: A paradoxical event. Australasian Journal of Dermatology. 65(8). e270–e272.

Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2024). Clinical characteristics and response to biological therapies for inverse psoriasis: a real‐life comparison between the therapeutic effects of anti‐IL ‐23 and anti‐IL ‐17 agents. International Journal of Dermatology. 63(12). 1735–1739. 3 indexed citations

Mastorino, Luca, Caterina Cariti, Niccolò Siliquini, et al.. (2023). Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study. Dermatologic Therapy. 2023(1). 2 indexed citations

10.

Mastorino, Luca, Paolo Dapavo, Francesco Leo, et al.. (2023). Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology. 38(3). 568–575. 11 indexed citations

11.

Mastorino, Luca, et al.. (2023). Ocular Adverse Events in Patients with Atopic Dermatitis Treated with Upadacitinib: A Real-Life Experience. Dermatitis. 34(5). 445–447. 8 indexed citations

12.

Eyerich, Kilian, Melinda Gooderham, Stephen Shumack, et al.. (2023). Real‐world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study. Journal of the European Academy of Dermatology and Venereology. 38(2). 340–353. 26 indexed citations

13.

Mastorino, Luca, Paolo Frigatti, Gabriele Roccuzzo, et al.. (2023). Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study. Expert Opinion on Biological Therapy. 23(9). 929–936. 10 indexed citations

14.

Giordano, Silvia, Paolo Dapavo, Michela Ortoncelli, et al.. (2023). Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience. Journal of Clinical Medicine. 12(24). 7503–7503. 7 indexed citations

15.

Mastorino, Luca, et al.. (2023). Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study. Journal of Clinical Medicine. 12(23). 7215–7215. 6 indexed citations

16.

Mastorino, Luca, Paolo Dapavo, Caterina Cariti, et al.. (2023). Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(1). 34–42. 24 indexed citations

17.

Mastorino, Luca, Niccolò Siliquini, Gianluca Avallone, et al.. (2022). Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis. Dermatology Reports. 14(3). 9282–9282. 5 indexed citations

18.

Mastorino, Luca, et al.. (2022). Lichen ruber planus arising during dupilumab treatment for atopic dermatitis. Italian Journal of Dermatology and Venereology. 157(5). 449–450. 6 indexed citations

19.

Avallone, Gianluca, Mattia Trunfio, Niccolò Siliquini, et al.. (2021). Dupilumab in HIV-positive patients with atopic dermatitis: a long-term follow-up patient and a literature review. Dermatology Online Journal. 27(8). 9 indexed citations

20.

Fierro, Maria Teresa, Mauro Novelli, Pietro Quaglino, et al.. (2008). Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma. Dermatology. 216(3). 213–221. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact